Today's Top Stories | | By Gabriel Osorio-Mazilli | March 6, 2025 09:12 AM |
| | | By The Associated Press | March 6, 2025 06:38 AM |
| | By Thomas Hughes | March 5, 2025 11:44 AM |
| | | By The Associated Press | March 6, 2025 05:55 AM |
| | By Gabriel Osorio-Mazilli | March 6, 2025 08:50 AM |
|
|
Your Watchlist | | | | - COO Javier Olivan sold 608 shares of Meta Platforms stock in a transaction that occurred on Monday, March 3rd. The shares were sold at an average price of $673.96, for a total value of $409,767.68. Following the transaction, the chief operating officer now owns 8,662 shares of the company's stock, valued at $5,837,841.52. The trade was a 6.56 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link.
- (3/6) Salesforce cuts diversity hiring goals, joining Meta and Google in scaling back DEI initiatives (businessinsider.com)
- (3/6) Only one stock can be bought—should $40K go into Meta or Tesla? (247wallst.com)
- (3/6) Meta Platforms, Inc. (NASDAQ:META) COO Javier Olivan Sells 608 Shares (marketbeat.com)
- (3/6) AIMZ Investment Advisors LLC Lowers Position in Meta Platforms, Inc. (NASDAQ:META) (marketbeat.com)
- (3/6) Scientific American User Advances Suit Over Meta Info Sharing (news.bloomberglaw.com)
| |
| Manage Your Watchlist
|
Analysts' Upgrades | ALX Oncology (NASDAQ:ALXO) was upgraded by analysts at Jefferies Financial Group Inc. from a "hold" rating to a "buy" rating. They now have a $3.00 price target on the stock, up previously from $2.00. This represents a 128.1% upside from the current price of $1.32. | Celanese (NYSE:CE) was upgraded by analysts at Vertical Research from a "sell" rating to a "hold" rating. They now have a $66.00 price target on the stock. This represents a 20.9% upside from the current price of $54.59. | CubeSmart (NYSE:CUBE) was upgraded by analysts at KeyCorp from a "sector weight" rating to an "overweight" rating. They now have a $47.00 price target on the stock. This represents a 12.0% upside from the current price of $41.96. | Caesars Entertainment (NASDAQ:CZR) was upgraded by analysts at Susquehanna from a "negative" rating to a "neutral" rating. They now have a $30.00 price target on the stock. This represents a 0.1% downside from the current price of $30.02. | Freeport-McMoRan (NYSE:FCX) was upgraded by analysts at Deutsche Bank Aktiengesellschaft from a "hold" rating to a "buy" rating. They now have a $47.00 price target on the stock. This represents a 23.4% upside from the current price of $38.10. | Marvell Technology (NASDAQ:MRVL) was upgraded by analysts at Loop Capital from a "hold" rating to a "buy" rating. They now have a $110.00 price target on the stock. This represents a 48.9% upside from the current price of $73.87. | CarParts.com (NASDAQ:PRTS) was upgraded by analysts at Craig Hallum from a "hold" rating to a "buy" rating. They now have a $3.00 price target on the stock. This represents a 146.9% upside from the current price of $1.22. | Walker & Dunlop (NYSE:WD) was upgraded by analysts at Keefe, Bruyette & Woods from a "market perform" rating to an "outperform" rating. They now have a $105.00 price target on the stock. This represents a 22.7% upside from the current price of $85.59. | XPO (NYSE:XPO) was upgraded by analysts at Vertical Research from a "hold" rating to a "buy" rating. They now have a $140.00 price target on the stock. This represents a 22.6% upside from the current price of $114.24. | Full Truck Alliance (NYSE:YMM) was upgraded by analysts at JPMorgan Chase & Co. from a "neutral" rating to an "overweight" rating. They now have a $18.00 price target on the stock, up previously from $13.00. This represents a 37.8% upside from the current price of $13.07. | Zscaler (NASDAQ:ZS) was upgraded by analysts at Rosenblatt Securities from a "neutral" rating to a "buy" rating. They now have a $235.00 price target on the stock, up previously from $190.00. This represents a 12.1% upside from the current price of $209.56. |
| View More Upgrades
|
Analysts' Downgrades | Arbe Robotics (NASDAQ:ARBE) was downgraded by analysts at Maxim Group from a "buy" rating to a "hold" rating.The current price is $1.35. | Brown-Forman (NYSE:BF.B) was downgraded by analysts at Morgan Stanley from an "equal weight" rating to an "underweight" rating. They now have a $32.00 price target on the stock, down previously from $47.00. This represents a 7.0% downside from the current price of $34.40. | Campbell Soup (NASDAQ:CPB) was downgraded by analysts at JPMorgan Chase & Co. from an "overweight" rating to a "neutral" rating. They now have a $37.00 price target on the stock, down previously from $48.00. This represents a 5.7% downside from the current price of $39.23. | MongoDB (NASDAQ:MDB) was downgraded by analysts at Wells Fargo & Company from an "overweight" rating to an "equal weight" rating. They now have a $225.00 price target on the stock, down previously from $365.00. This represents a 7.7% upside from the current price of $208.98. | Marvell Technology (NASDAQ:MRVL) was downgraded by analysts at Summit Insights from a "buy" rating to a "hold" rating.The current price is $73.87. | VersaBank (NASDAQ:VBNK) was downgraded by analysts at Roth Mkm from a "buy" rating to a "neutral" rating. They now have a $10.40 price target on the stock, down previously from $22.00. This represents a 0.8% upside from the current price of $10.32. |
| View More Downgrades
|
Analysts' New Coverage | Aduro Clean Technologies (NASDAQ:ADUR) is now covered by analysts at D. Boral Capital. They set a "buy" rating and a $50.00 price target on the stock. This represents a 910.1% upside from the current price of $4.95. | Robinhood Markets (NASDAQ:HOOD) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating and a $69.00 price target on the stock. This represents a 43.9% upside from the current price of $47.95. | ImmunityBio (NASDAQ:IBRX) is now covered by analysts at HC Wainwright. They set a "buy" rating and a $8.00 price target on the stock. This represents a 161.2% upside from the current price of $3.06. | Insulet (NASDAQ:PODD) is now covered by analysts at Royal Bank of Canada. They set an "outperform" rating and a $340.00 price target on the stock. This represents a 27.5% upside from the current price of $266.69. | Tourmaline Bio (NASDAQ:TRML) is now covered by analysts at Wedbush. They set an "outperform" rating and a $42.00 price target on the stock. This represents a 214.1% upside from the current price of $13.37. |
| View More New Coverage
|
Calendars from MarketBeat | |
|
Get 30 Days of MarketBeat All Access Free | Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: | Best-in-Class Portfolio MonitoringView the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.Stock Ideas and RecommendationsGet daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.Advanced Stock Screeners and Research ToolsIdentify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.
| Start Your 30-Day Free Trial |
| Upgrade Your Subscription | Upgrade to MarketBeat All Access and receive your premium edition of MarketBeat Daily at 9:00 AM ET. | Upgrade Now |
|
| Manage Your Watchlist | View and add up to five holdings to your watchlist. | View My Portfolio |
|
| Join Our Facebook Group | Join MarketBeat's free stock discussion and trading idea group on Facebook. | Join Now |
|
|
No comments:
Post a Comment